Recent Posts
- And that’s a wrap 2023! Christmas with IR Department
- This is what the ASX and investors expect for gender diversity on your board
- 5 key lessons any company can take away from our foundational ESG report
- What small caps can take away from Amazon’s move to write emissions data into its supplier standards
- How Australian small caps are likely to be impacted by the new ISSB sustainability disclosure standards
Archives
Race Oncology speaks to Proactive Investor as part of the ASX Small and Mid-Cap Conference
Race Oncology (ASX:RAC) CEO Phil Lynch provides an update on the Company’s activities and new strategy as part of their participation in the ASX Small and Mid-Cap Conference 2022.